IOVA vs RVTY · rev $263.5M vs P/E 42, rev $1.44B
Iovance Biotherapeutics Inc (IOVA) versus Revvity Inc. (RVTY) — a side-by-side from cached financials, not a winner call.
Iovance Biotherapeutics Inc (IOVA) is a biotechnology company listed on US.
Revvity Inc. (RVTY) is a diagnostics & research company listed on US.
Latest reported IOVA revenue for 2025-12-31 was $263.5M. Net income was -$391.0M. IOVA currently screens at market cap $1.89B.
Latest reported RVTY revenue for 2026-07-05 was $1.44B. Net income was $92.5M. RVTY currently screens at market cap $11.94B and trailing P/E 41.9.
IOVA currently screens at market cap $1.89B. RVTY currently screens at market cap $11.94B and trailing P/E 41.9.
Not investment advice. Open the IOVA and RVTY stock pages for the full models.
Not investment advice.